Back to 
Renaissance Technologies LLC
Renaissance Technologies LLC
MNPR
Showing 0 of 2 quarters
Position history for Renaissance Technologies LLC's holdings in Monopar Therapeutics Inc.
No. Renaissance Technologies exited its MNPR (Monopar Therapeutics) position in Q1 2024. Its Q4 2023 13F listed 48,086 shares worth $16,000. Renaissance Technologies first reported MNPR in Q4 2023 and held it in 1 quarterly 13F filing.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.